Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL)

Clinical trial NCT01212380 · COMPLETED

Trial details

NCT number: NCT01212380
Sponsor: Ohio State University Comprehensive Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

B-cell Chronic Lymphocytic Leukemia Hematopoietic/Lymphoid Cancer Prolymphocytic Leukemia Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia

Start date: 2010-10-01
Primary completion: 2014-07-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.